Publications


2018

Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.Strand F, Humphreys K, Holm J, Eriksson M, Törnberg S, Hall P, Azavedo E, Czene K. Breast Cancer Res. 2018 Apr 18;20(1):31. doi: 10.1186/s13058-018-0962-6.

Common genetic variation and novel loci associated with volumetric mammographic density. Brand JS, Humphreys K, Li J, Karlsson R, Hall P, Czene K. Breast Cancer Res. 2018 Apr 17;20(1):30. doi: 10.1186/s13058-018-0954-6.

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast. Gabrielson M, Chiesa F, Behmer C, Rönnow K, Czene K, Hall P. Breast Cancer Res Treat. 2018 Mar 30. doi: 10.1007/s10549-018-4768-0. [Epub ahead of print]

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons MT, Li H, De Vecchi G, Tudini E, et al. Hum Mutat. 2018 May;39(5):729-741. doi: 10.1002/humu.23411. Epub 2018 Apr 6.

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density. Byström S, Eklund M, Hong MG, Fredolini C, Eriksson M, Czene K, Hall P, Schwenk JM, Gabrielson M.Breast Cancer Res. 2018 Feb 14;20(1):14. doi: 10.1186/s13058-018-0940-z.

A comprehensive tool for measuring mammographic density changes over time. Eriksson M, Li J, Leifland K, Czene K, Hall P Breast Cancer Res Treat. 2018 Jun;169(2):371-379. doi: 10.1007/s10549-018-4690-5. Epub 2018 Feb 1.

Inherited factors contribute to an inverse association between preeclampsia and breast cancer. Yang H, He W, Eriksson M, Li J, Holowko N, Chiesa F, Hall P, Czene K. Breast Cancer Res. 2018 Jan 23;20(1):6. doi: 10.1186/s13058-017-0930-6.

Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium. Rudolph A, Song M, Brook MN, Milne RL, Mavaddat N, Michailidou K, Bolla MK, Wang Q, et al. Int J Epidemiol. 2018 Apr 1;47(2):526-536. doi: 10.1093/ije/dyx242.

 

2017

PHIP – a novel candidate breast cancer susceptibility locus on 6q14.1. Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, et al. Oncotarget. 2017 Oct 12;8(61):102769-102782. doi: 10.18632/oncotarget.21800. eCollection 2017 Nov 28.

Associations between childhood body size and seventeen adverse outcomes: analysis of 65,057 European women. Li J, Eriksson M, He W, Hall P, Czene K. Sci Rep. 2017 Dec 5;7(1):16917. doi: 10.1038/s41598-017-17258-5.

Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, Wildiers H, et al. Breast Cancer Res. 2017 Nov 7;19(1):119. doi: 10.1186/s13058-017-0909-3.

Association analysis identifies 65 new breast cancer risk loci. Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, et al. Nature. 2017 Nov 2;551(7678):92-94. doi: 10.1038/nature24284. Epub 2017 Oct 23.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, et al. Nat Genet. 2017 Dec;49(12):1767-1778. doi: 10.1038/ng.3785. Epub 2017 Oct 23.

Breast Tissue Organisation and its Association with Breast Cancer Risk. Ali MA, Czene K, Eriksson L, Hall P, Humphreys K. Breast Cancer Res. 2017 Sep 6;19(1):103. doi: 10.1186/s13058-017-0894-6.

Risk and predictors of psoriasis in patients with breast cancer: a Swedish population-based cohort study. Yang H, Brand JS, Li J, Ludvigsson JF, Ugalde-Morales E, Chiesa F, Hall P, Czene K. BMC Med. 2017 Aug 11;15(1):154. doi: 10.1186/s12916-017-0915-4.

Common shared genetic variation behind decreased risk of breast cancer in celiac disease. Ugalde-Morales E, Li J, Humphreys K, Ludvigsson JF, Yang H, Hall P, Czene K. Sci Rep. 2017 Jul 19;7(1):5942. doi: 10.1038/s41598-017-06287-9.

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium. Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching PA, Beckmann MW, Gago-Dominguez M, et al. Int J Cancer. 2017 Nov 1;141(9):1830-1840. doi: 10.1002/ijc.30859. Epub 2017 Aug 11.

Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach. Andersson TM, Crowther MJ, Czene K, Hall P, Humphreys K. Am J Epidemiol. 2017 Nov 1;186(9):1065-1073. doi: 10.1093/aje/kwx178.

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity. Holm J, Eriksson L, Ploner A, Eriksson M, Rantalainen M, Li J, Hall P, Czene K. Cancer Res. 2017 Jul 1;77(13):3708-3717. doi: 10.1158/0008-5472.CAN-16-2574. Epub 2017 May 16.

Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, et al. Nat Genet. 2017 Jun;49(6):834-841. doi: 10.1038/ng.3841. Epub 2017 Apr 24.

Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients. He W, Smedby KE, Fang F, Olsson H, Margolin S, Hall P, Czene K. J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx041.

A clinical model for identifying the short-term risk of breast cancer. Eriksson M, Czene K, Pawitan Y, Leifland K, Darabi H, Hall P. Breast Cancer Res. 2017 Mar 14;19(1):29. doi: 10.1186/s13058-017-0820-y.

BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calléja FMGR, Meeks H, et al. Cancer Res. 2017 Jun 1;77(11):2789-2799. doi: 10.1158/0008-5472.CAN-16-2568. Epub 2017 Mar 10.

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA). Gabrielson M, Eriksson M, Hammarström M, Borgquist S, Leifland K, Czene K, Hall P. Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g. doi: 10.1093/ije/dyw357. No abstract available.

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, et al. Oncotarget. 2017 Mar 14;8(11):18381-18398. doi: 10.18632/oncotarget.15110.

Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry. Wen W, Shu XO, Guo X, Cai Q, Long J, Bolla MK, Michailidou K, Dennis J, Wang Q, et al. Breast Cancer Res. 2016 Dec 8;18(1):124.

Breaking the matching in nested case-control data offered several advantages for risk estimation. Delcoigne B, Colzani E, Prochazka M, Gagliardi G, Hall P, Abrahamowicz M, Czene K, Reilly M. J Clin Epidemiol. 2017 Feb;82:79-86. doi: 10.1016/j.jclinepi.2016.11.014. Epub 2016 Dec 5.

Differences in mammographic density between Asian and Caucasian populations: a comparative analysis. Rajaram N, Mariapun S, Eriksson M, Tapia J, Kwan PY, Ho WK, Harun F, Rahmat K, al. Breast Cancer Res Treat. 2017 Jan;161(2):353-362. doi: 10.1007/s10549-016-4054-y. Epub 2016 Nov 18.

Time-dependent risk of depression, anxiety, and stress-related disorders in patients with invasive and in situ breast cancer.Yang H, Brand JS, Fang F, Chiesa F, Johansson AL, Hall P, Czene K. Int J Cancer. 2017 Feb 15;140(4):841-852. doi: 10.1002/ijc.30514. Epub 2016 Nov 25.

 

2016

rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk. Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, et al. Sci Rep. 2016 Nov 15;6:36874. doi: 10.1038/srep36874.

Chemotherapy, Genetic Susceptibility, and Risk of Venous Thromboembolism in Breast Cancer Patients. Brand JS, Hedayati E, Humphreys K, Ludvigsson JF, Johansson AL, Bergh J, Hall P, Czene K.  Clin Cancer Res. 2016 Nov 1;22(21):5249-525

Common diseases as determinants of menopausal age.Li J, Eriksson M, Czene K, Hall P, Rodriguez-Wallberg KA. Hum Reprod. 2016 Oct 18. PMID: 27798047

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, et al. Oncotarget. 2016 Oct 21. doi: 10.18632/oncotarget.12818. PMID: 27792995

Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K.  Cancer. 2016 Oct 11. doi: 10.1002/cncr.30364. PMID: 27727456

Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, Kaufmann S, et al. Am J Hum Genet. 2016 Oct 6;99(4):903-911. doi: 10.1016/j.ajhg.2016.07.017. PMID: 27640304

Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.Colzani E, Clements M, Johansson AL, Liljegren A, He W, Brand J, Adolfsson J, Fornander T, Hall P, Czene K. . Br J Cancer. 2016 Oct 4. doi: 10.1038/bjc.2016.314. PMID: 27701383

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk.Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PD, et al.  Genet Med. 2016 Oct 6. doi: 10.1038/gim.2016.147. PMID: 27711073

Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study. Strand F, Humphreys K, Cheddad A, Törnberg S, Azavedo E, Shepherd J, Hall P, Czene K.  Breast Cancer Res. 2016 Oct 5;18(1):100. PMID: 27716311

Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium. Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, et al.  Breast Cancer Res. 2016 Oct 3;18(1):98. PMID: 27716369

Genetic predisposition to ductal carcinoma in situ of the breast.Christos Petridis, Mark N. Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, et al.  Breast Cancer Res. 2016; 18: 22. Published online 2016 Feb 17. doi: 10.1186/s13058-016-0675-7. PMCID: PMC4756509

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study.Frida E. Lundberg, Anna L. V. Johansson, Kenny Rodriguez-Wallberg, Judith S. Brand, Kamila Czene, Per Hall, Anastasia N. Iliadou.  Breast Cancer Res. 2016; 18: 36. Published online 2016 Apr 13. doi: 10.1186/s13058-016-0693-5. PMCID: PMC4830010

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.Hisani N. Horne, Charles C. Chung, Han Zhang, Kai Yu, Ludmila Prokunina-Olsson, Kyriaki Michailidou, Manjeet K. Bolla, et al.  PLoS One. 2016; 11(8): e0160316. Published online 2016 Aug 24. doi: 10.1371/journal.pone.0160316. PMCID: PMC4996485

Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer. Strand F, Humphreys K, Eriksson M, Li J, Andersson TM, Törnberg S, Azavedo E, Shepherd J, et al.  Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30427. [Epub ahead of print] PMID: 27615710

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, et al.  Nat Commun. 2016 Sep 7;7:12675. doi: 10.1038/ncomms12675. PMID: 27601076

Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).Darabi H, Beesley J, Droit A, Kar S, Nord S, Moradi Marjaneh M, Soucy P, Michailidou K, et al.  Sci Rep. 2016 Sep 7;6:32512. doi: 10.1038/srep32512. PMID: 27600471

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, et al.  J Med Genet. 2016 Sep 5. pii: jmedgenet-2016-103839. doi: 10.1136/jmedgenet-2016-103839. PMID: 27595995

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. Horne HN, Chung CC, Zhang H, Yu K, Prokunina-Olsson L, Michailidou K, Bolla MK, Wang Q, et al.  PLoS One. 2016 Aug 24;11(8):e0160316. doi: 10.1371/journal.pone.0160316. eCollection 2016. PMID: 27556229

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Decadence.Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, et al.  PLoS Med. 2016 Aug 23;13(8):e1002105. doi: 10.1371/journal.pmed.1002105. eCollection 2016 Aug. PMID: 27551723

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, et al.  Breast Cancer Res. 2016 Jun 21;18(1):64. doi: 10.1186/s13058-016-0718-0.

Worse quality of life in young and recently-diagnosed breast cancer survivors compared to female survivors of other cancers: A cross-sectional study. Li J, Humphreys K, Eriksson M, Dar H, Brandberg Y, Hall P, Czene K.  Int J Cancer. 2016 Aug 3. doi: 10.1002/ijc.30370. PMID: 27486698

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression.Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, et al.  Hum Mol Genet. 2016 Jul 11. pii: ddw223. [Epub ahead of print] PMID: 27402876

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues. Gabrielson M, Chiesa F, Paulsson J, Strell C, Behmer C, Rönnow K, Czene K, Östman A, et al.  Breast Cancer Res Treat. 2016 Jul;158(2):253-61. doi: 10.1007/s10549-016-3877-x. Epub 2016 Jun 27. PMID: 27349429

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. SchmidtMK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, et al. J Clin Oncol. 2016 Jun 6. pii: JCO665844. [Epub ahead of print]. PMID: 27269948

RAD51B in Familial Breast Cancer. Pelttari LM, Khan S, Vuorela M, Kiiski JI, Vilske S, Nevanlinna V, Ranta S, Schleutker J, et al.  PLoS One. 2016 May 5;11(5):e0153788. doi: 10.1371/journal.pone.0153788. eCollection 2016.. PMID: 27149063

Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis. Brand JS, Colzani E, Johansson AL, Giesecke J, Clements M, Bergh J, Hall P, Czene K.  J Infect. 2016 Apr 8. pii: S0163-4453(16)30030-5. doi: 10.1016/j.jinf.2016.04.003. [Epub ahead of print]. PMID: 27063280

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study. Lundberg FE, Johansson AL, Rodriguez-Wallberg K, Brand JS, Czene K, Hall P, Iliadou AN.  Breast Cancer Res. 2016 Apr 13;18(1):36. doi: 10.1186/s13058-016-0693-5. PMID: 27072636 [PubMed – in process]

Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, et al.  Int J Cancer. 2016 Apr 18. doi: 10.1002/ijc.30150. [Epub ahead of print]. PMID: 27087578 [PubMed – as supplied by publisher]

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. CouchFJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, et al. Nat Commun. 2016 Apr 27;7:11375. doi: 10.1038/ncomms11375. PMID: 27117709 [PubMed – in process]

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, et al.  Cancer Causes Control. 2016 Apr 6. [Epub ahead of print]

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.Li J, Holm J, Bergh J, Eriksson M, Darabi H, Lindström LS, Törnberg S, Hall P, et al.  Ann Oncol. 2016 Mar 3. pii: mdw096. [Epub ahead of print] No abstract available.

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, et al.  J Med Genet. 2016 Feb 26. pii: jmedgenet-2015-103529. doi: 10.1136/jmedgenet-2015-103529.

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, Kar S, et al. Nat Genet. 2016 Feb 29. doi: 10.1038/ng.3521.

Genetic predisposition to ductal carcinoma in situ of the breast. Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, Papouli E, et al.  Breast Cancer Res. 2016 Feb 17;18(1):22.

 

2015

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.Seibold P, Schmezer P, Behrens S, Michailidou K, Bolla MK, Wang Q, Flesch-Janys D, et al.  BMC Cancer. 2015 Dec 16;15(1):978. doi: 10.1186/s12885-015-1957-7. PMID: 26674097

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sabine Behrens, Ellen L. Goode, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, et al.  Hum Genet. 2016; 135: 137–154. Published online 2015 Nov 30. doi: 10.1007/s00439-015-1616-8. PMCID: PMC4698282

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis. Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, Hall P, Czene K.  J Clin Oncol. 2015 Nov 30. pii: JCO630624. [Epub ahead of print]. PMID: 26628467

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, Dunning AM, et al.  Hum Genet. 2015 Nov 30. [Epub ahead of print]

In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women-A GWAS Study Using the iCOGS Custom Genotyping Array.Schoormans D, Darabi H, Li J, Brandberg Y, Eriksson M, Zwinderman KH, Sprangers MA, Hall P.  PLoS One. 2015 Oct 15;10(10):e0140563. doi: 10.1371/journal.pone.0140563. eCollection 2015. PMID: 26469178

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, et al.  Nat Genet. 2015 Sep 28. doi: 10.1038/ng.3412. [Epub ahead of print]

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Milne RLet al. Cancer Epidemiol Biomarkers Prev. 2015 Sep 9. pii: cebp.0363.2015. [Epub ahead of print]

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. O’Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J; Australian National Endometrial Cancer Study Group (ANECS), et al.  Endocr Relat Cancer. 2015 Oct;22(5):851-61. doi: 10.1530/ERC-15-0319.

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, Darabi H, Li J, Andrulis IL, et al.  Oncotarget. 2015 Jul 22. [Epub ahead of print]

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.Ben Zhang, Xiao-Ou Shu, Ryan J. Delahanty, Chenjie Zeng, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, et al. J Natl Cancer Inst (2015) 107(11): djv219

Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data. Abrahamsson L, Czene K, Hall P, Humphreys K.  Breast Cancer Res. 2015 Aug 21;17(1):116. doi: 10.1186/s13058-015-0614-z.

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.Rudolph A, Fasching PA, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, Czene K, et al.  Breast Cancer Res. 2015 Aug 16;17(1):110. doi:

Comments are closed.